Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nil Irem Ucgun

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Ophthalmology|March 24, 2021
Macular pigment optical density change analysis in primary open-angle glaucoma and pseudoexfoliation glaucomaCenk Zeki Fikret, Nil Irem Ucgun
Clinics (Sao Paulo, Brazil)|July 27, 2011
The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degenerationZuhal Yildirim, Nil Irem Ucgun, Filiz Yildirim
Molecular Vision|November 19, 2020
Inflammation and diabetic retinopathyNil Irem Ucgun, Cenk Zeki-Fikret, Zuhal Yildirim
Current Stem Cell Research & Therapy|March 20, 2024
Bone Marrow-derived Mesenchymal Stem Cell Therapy in Retinitis PigmentosaNil Irem Ucgun, Cenk Zeki Fikret, Mualla Sahin Hamurcu
Photodiagnosis and Photodynamic Therapy|November 6, 2023
Early effects of cardiopulmonary bypass surgery on retinal nerve fiber layer and ganglion cell layerCenk Zeki Fikret, Erdal Simsek, Nil Irem Ucgun, et al.
Photodiagnosis and Photodynamic Therapy|April 8, 2023
Corneal characteristics in patients with retinitis pigmentosaCenk Zeki Fikret, Nil Irem Ucgun, Emine Esra Karaca, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept SwitchMurat Kucukevcilioglu, Yağmur Seda Yeşiltaş, Ali Hakan Durukan, et al.
International Ophthalmology|July 13, 2022
Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 monthsAli Hakan Durukan, Nurten Unlu, Mehmet Onen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Ophthalmology|March 24, 2021
Macular pigment optical density change analysis in primary open-angle glaucoma and pseudoexfoliation glaucomaCenk Zeki Fikret, Nil Irem Ucgun
Clinics (Sao Paulo, Brazil)|July 27, 2011
The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degenerationZuhal Yildirim, Nil Irem Ucgun, Filiz Yildirim
Molecular Vision|November 19, 2020
Inflammation and diabetic retinopathyNil Irem Ucgun, Cenk Zeki-Fikret, Zuhal Yildirim
Current Stem Cell Research & Therapy|March 20, 2024
Bone Marrow-derived Mesenchymal Stem Cell Therapy in Retinitis PigmentosaNil Irem Ucgun, Cenk Zeki Fikret, Mualla Sahin Hamurcu
Photodiagnosis and Photodynamic Therapy|November 6, 2023
Early effects of cardiopulmonary bypass surgery on retinal nerve fiber layer and ganglion cell layerCenk Zeki Fikret, Erdal Simsek, Nil Irem Ucgun, et al.
Photodiagnosis and Photodynamic Therapy|April 8, 2023
Corneal characteristics in patients with retinitis pigmentosaCenk Zeki Fikret, Nil Irem Ucgun, Emine Esra Karaca, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept SwitchMurat Kucukevcilioglu, Yağmur Seda Yeşiltaş, Ali Hakan Durukan, et al.
International Ophthalmology|July 13, 2022
Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 monthsAli Hakan Durukan, Nurten Unlu, Mehmet Onen, et al.
Pageof 1